<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="38854" whole_study_id="38854" phs="002212" v="1" p="1" createDate="2020-07-15T08:54:43-05:00" completedByGPADate="2020-07-20T08:42:06-05:00" modDate="2022-01-25T16:16:23-05:00" maxParentChildStudyModDate="2022-01-25T16:16:23-05:00" handle="ZRSR2_MDS" num_participants="19"><StudyInfo accession="phs002212.v1.p1" parentAccession="phs002212.v1.p1"><BioProject id="PRJNA671387" entrez_id="671387" type="bp_admin_access"/><BioProject id="PRJNA671388" entrez_id="671388" type="bp_data_submission"/><StudyNameEntrez>ZRSR2 mutant myelodysplastic syndromes</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="rnaseq_whole_targ_transcriptome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="rna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>rna</StudyType><StudyType>whole_transcriptome</StudyType><StudyType>rna_seq_derived_expression</StudyType></StudyTypes><Funding>R01HL128239</Funding></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="ABDELWAO" aid="2" auth="eRA" login="ABDELWAO" fname="Omar" mname="" lname="Abdel-Wahab" email="abdelwao@mskcc.org"><Role allow_direct_access="true">PI</Role><Organization>SLOAN-KETTERING INST CAN RESEARCH</Organization></Person><Person nedid="2001740593" aid="1" auth="cit" login="yangy23" fname="Yu-Chung" mname="" lname="Yang" email="yu-chung.yang@nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person aid="8" auth="virtual" fname="Pavitra" lname="Rao" email="raop@mskcc.org"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001545300" aid="1" auth="cit" login="lic17" fname="Chengyuan" mname="" lname="Press" email="chanel.press@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>The ZRSR2 mutant myelodysplastic syndromes study was supported by the Conquer Cancer Foundation of the American Society of Clinical Oncology (Justin Taylor), American Association for Cancer Research (Justin Taylor), American Society of Hematology (Justin Taylor), Robert Wood Johnson Foundation (Justin Taylor), NIH grants 1K08CA230319-01 (Justin Taylor), T32 CA009657 (Jacob T. Polaski), R01 DK103854 (Robert K. Bradley), and R01 HL128239 (Robert K. Bradley and Omar Abdel-Wahab), the Dept. of Defense Bone Marrow Failure Research Program (W81XWH-12-1-0041; Robert K. Bradley and Omar Abdel-Wahab), Leukemia &amp; Lymphoma Society (Daichi Inoue and Omar Abdel-Wahab), Henry &amp; Marilyn Taub Foundation (Omar Abdel-Wahab), and Evans MDS Foundation (Jacob T. Polaski, Justin Taylor, Omar Abdel-Wahab and Robert K. Bradley).   Daichi Inoue is supported by Japan Agency for Medical Research and Development, Takeda Science Foundation, MDS Foundation, The Yasuda Medical Foundation, The Kanae Foundation for the Promotion of Medical Science, MSD Life Science Foundation, Bristol Myers Squibb Foundation, and Leukemia Research Foundation. Robert K. Bradley is a Scholar of The Leukemia &amp; Lymphoma Society (1344-18). The results for ZRSR2 mutant myelodysplastic syndromes study are in part based upon data generated by the TCGA Research Network: https://cancergenome.nih.gov/. The original data is described in &#8220;Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition&#8221; (journal reference______________) (PMID:______________). The original data is deposited in the National Institutes of Health database of Genotypes and Phenotypes (dbGaP) phs_______.&#8221;</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access" gsr_mode_label="Controlled-access (GSR are sensitive according to the Institutional Certification)"/><ConsentGroup uid="4057" CGType="cg_class_HMB" title="Health/Medical/Biomedical" name="HMB" dac_uid="56" dac_name="NHLBI" irb-approval-required="No"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>